WASHINGTON DC (January 16, 2020) – “The Association for Accessible Medicines strongly endorses the Senate’s bipartisan passage of the U.S.-Mexico-Canada Agreement. For the first time in a trade agreement, a balance between support for innovation and access to affordable medicines has been reached. This balance will not only allow the growth of U.S. brand, generic and biosimilar pharmaceutical companies, but will also support increased access to competitively priced medicines in the United States.
Access! 2020 - Early-bird special: Save $500 off full-pass registration when you register by Feb 10.